PATENT CLAIM ANALYSIS

Application Number: 16027206
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "215100"]

Abstract:
The invention provides for modified reovirus nucleic acid sequences and modified reovirus polypeptide sequences as well as reoviruses containing such modified nucleic acid or polypeptide sequences. The invention also provides for pharmaceutical compositions that include reoviruses having a modified sequence as well as methods of making and using such reoviruses.

Claim (Index 54):
The method of claim  1 , wherein the reovirus comprises a mu-2 polypeptide comprising SEQ 1D NO:16.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 95.0
- Lexical Diversity: 1.73333
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14179840', '12848684', '12046095', '11997537', '15246109']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7276020159351813
- 35 USC 102 Novelty (BERT): 0.6064484193873994
- Combined Prediction Score: 0.7154866562804031
- Mean Citation Score: 412.15102800000005
- Max Citation Score: 525.06976
- Similarity Product: 489.247800801468

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test